poly(epsilon- caprolactone)- poly(oxyethylene)- poly(epsilon- caprolactone)

a triblock copolymer

Also Known As:

PCL-PEO-PCL; PCL-POE-PCL; poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone); poly-(epsilon-caprolactone)-poly-(oxyethylene)-poly-(epsilon-caprolactone)

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Macromolecular Substances: 97
- Polymers: 13051
  - Polyethylene Glycols: 3865
    - poly(epsilon-caprolactone)-poly(oxyethylene)-poly(epsilon-caprolactone): 2
  - Polyesters: 921
    - poly(epsilon-caprolactone)-poly(oxyethylene)-poly(epsilon-caprolactone): 2
Biomedical and Dental Materials
- Polymers: 13051
  - Polyethylene Glycols: 3865
    - poly(epsilon-caprolactone)-poly(oxyethylene)-poly(epsilon-caprolactone): 2
  - Polyesters: 921
    - poly(epsilon-caprolactone)-poly(oxyethylene)-poly(epsilon-caprolactone): 2
Technology, Industry, and Agriculture
- Manufactured Materials
  - Biomedical and Dental Materials
    - Polymers: 13051
      - Polyethylene Glycols: 3865
        poly(epsilon-caprolactone)-poly(oxyethylene)-poly(epsilon-caprolactone): 2
      - Polyesters: 921
        poly(epsilon-caprolactone)-poly(oxyethylene)-poly(epsilon-caprolactone): 2
Organic Chemicals: 133
- Alcohols: 595
  - Glycols: 38
    - Ethylene Glycols: 8
      - Polyethylene Glycols: 3865
        poly(epsilon-caprolactone)-poly(oxyethylene)-poly(epsilon-caprolactone): 2

Experts

1.	Chen, Xiaoxin: 1 article (03/2013)
2.	Chu, Bingyang: 1 article (03/2013)
3.	Long, Chaofeng: 1 article (03/2013)
4.	Luo, Feng: 1 article (03/2013)
5.	Qian, Zhiyong: 1 article (03/2013)
6.	Wang, Cheng: 1 article (03/2013)
7.	Wang, Yujun: 1 article (03/2013)
8.	Xie, Chengshi: 1 article (03/2013)
9.	Zhang, Lan: 1 article (03/2013)
10.	Feng, Nianping: 1 article (07/2008)

Related Diseases

1.	Neoplasms (Cancer) 07/01/2008 - "The antitumor activity of ORI-PCL-PEO-PCL-NPs was evaluated by measuring changes in tumor volumes, tumor weights, and survival rates of mice with grafted hepatoma (H22). " 03/01/2013 - "In this paper, two nanoscale preparations were described for docetaxel encapsulation using poly(epsilon-caprolactone)poly(ethylene glycol)-poly(epsilon-caprolactone) (PCEC) copolymer as carrier for treating malignant tumor. "
2.	Liver Neoplasms (Liver Cancer) 07/01/2008 - "Thus, ORI-PCL-PEO-PCL-NPs may be used as a promising delivery system for liver cancer treatment."
3.	Hepatocellular Carcinoma (Hepatoma) 07/01/2008 - "The antitumor activity of ORI-PCL-PEO-PCL-NPs was evaluated by measuring changes in tumor volumes, tumor weights, and survival rates of mice with grafted hepatoma (H22). "

Related Drugs and Biologics

1.	Docetaxel (Taxotere)